PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjindmedLink to Publisher's site
 
Br J Ind Med. 1974 October; 31(4): 275–287.
PMCID: PMC1009598

Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: case report and other considerations

Abstract

Petkau, A., Sawatzky, A., Hillier, C. R., and Hoogstraten, J. (1974).British Journal of Industrial Medicine,31, 275-287. Lead content of neuromuscular tissue in amyotrophic lateral sclerosis. Case report and other considerations. In a case of amyotrophic lateral sclerosis, in which the occupational history and laboratory evidence indicated that exposure to lead had occured, it was found at necropsy that in tissues of nerve, spinal cord, and cardiac and skeletal muscle the lead content was 9·6 ± 0·3, 9·9 ± 1·7, 17·7, and 21·1 ± 5·1 μg/g of dry weight of tissue, respectively. Significantly elevated levels of lead were also found at necropsy in nerve, spinal cord, and muscle tissue in other cases of amyotrophic lateral sclerosis that had not been exposed to lead during life. A reassessment of the role of lead in amyotrophic lateral sclerosis is indicated.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (6.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Barry PS, Mossman DB. Lead concentrations in human tissues. Br J Ind Med. 1970 Oct;27(4):339–351. [PMC free article] [PubMed]
  • Bobowick AR, Brody JA. Epidemiology of motor-neuron diseases. N Engl J Med. 1973 May 17;288(20):1047–1055. [PubMed]
  • Campbell AM, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877–885. [PMC free article] [PubMed]
  • Cardona E, Lessler MA, Brierley GP. Mitochondrial oxidative phosphorylation: interaction of lead and inorganic phosphate. Proc Soc Exp Biol Med. 1971 Jan;136(1):300–304. [PubMed]
  • Carroll KG, Spinelli FR, Goyer RA. Electron probe microanalyser localization of lead in kidney tissue of poisoned rats. Nature. 1970 Sep 5;227(5262):1056–1056. [PubMed]
  • Chisolm JJ., Jr Lead poisoning. Sci Am. 1971 Feb;224(2):15–23. [PubMed]
  • Choie DD, Richter GW. Lead poisoning: rapid formation of intranuclear inclusions. Science. 1972 Sep 29;177(4055):1194–1195. [PubMed]
  • Currier RD, Haerer AF. Amyotrophic lateral sclerosis and metallic toxins. Arch Environ Health. 1968 Nov;17(5):712–719. [PubMed]
  • Goyer RA. Lead toxicity: a problem in environmental pathology. Am J Pathol. 1971 Jul;64(1):167–182. [PubMed]
  • Goyer RA, Krall R. Ultrastructural transformation in mitochondria isolated from kidneys of normal and lead-intoxicated rats. J Cell Biol. 1969 May;41(2):393–400. [PMC free article] [PubMed]
  • Goyer RA, Leonard DL, Moore JF, Rhyne B, Krigman MR. Lead dosage and the role of the intranuclear inclusion body. An experimental study. Arch Environ Health. 1970 Jun;20(6):705–711. [PubMed]
  • Haeger-Aronsen B. An assessment of the laboratory tests used to monitor the exposure of lead workers. Br J Ind Med. 1971 Jan;28(1):52–58. [PMC free article] [PubMed]
  • KEHOE RA. NORMAL METABOLISM OF LEAD. Arch Environ Health. 1964 Feb;8:232–235. [PubMed]
  • Koeppe DE, Miller RJ. Lead effects on corn mitochondrial respiration. Science. 1970 Mar 6;167(3923):1376–1378. [PubMed]
  • McIntire MS, Angle CR. Air lead: relation to lead in blood of black school children deficient in glucose-6-phosphate dehydrogenase. Science. 1972 Aug 11;177(4048):520–522. [PubMed]
  • MELLORS RC, CARROLL KG. A new method for local chemical analysis of human tissue. Nature. 1961 Dec 16;192:1090–1092. [PubMed]
  • PATTERSON CC. CONTAMINATED AND NATURAL LEAD ENVIRONMENTS OF MAN. Arch Environ Health. 1965 Sep;11:344–360. [PubMed]
  • Prerovská I, Teisinger J. Excretion of lead and its biological activity several years after termination of exposure. Br J Ind Med. 1970 Oct;27(4):352–355. [PMC free article] [PubMed]
  • Sauer RM, Zook BC, Garner FM. Demyelinating encephalomyelopathy associated with lead poisoning in nonhuman primates. Science. 1970 Sep 11;169(3950):1091–1093. [PubMed]
  • SIMPSON JA, SEATON DA, ADAMS JF. RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING. J Neurol Neurosurg Psychiatry. 1964 Dec;27:536–541. [PMC free article] [PubMed]
  • Soman SD, Joseph KT, Raut SJ, Mulay CD, Parameshwaran M, Panday VK. Studies on major and trace element content in human tissues. Health Phys. 1970 Nov;19(5):641–656. [PubMed]
  • TOUSIMIS AJ. SCANNING ELECTRON PROBE MICROANALYSIS OF BIOLOGICAL SPECIMENS. Biomed Sci Instrum. 1963;1:249–261. [PubMed]
  • Weiner LP, Johnson RT, Herndon RM. Viral infections and demyelinating diseases. N Engl J Med. 1973 May 24;288(21):1103–1110. [PubMed]
  • White JM, Harvey DR. Defective synthesis of and globin chains in lead poisoning. Nature. 1972 Mar 10;236(5341):71–73. [PubMed]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group